Page last updated: 2024-08-26

uvaol and 11-keto-boswellic acid

uvaol has been researched along with 11-keto-boswellic acid in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Aubry, EM; Brandstötter, S; Gumy, C; Kratschmar, DV; Odermatt, A; Pfisterer, PH; Rollinger, JM; Schuster, D; Stuppner, H; Wolber, G1
Fukushima, EO; Muranaka, T; Nomura, Y; Vo, NNQ1
Gou, W; Guo, J; Hou, W; Li, Y; Liu, Q; Ning, H; Shang, H; Sun, X; Wei, H1

Reviews

1 review(s) available for uvaol and 11-keto-boswellic acid

ArticleYear
Discovery of Natural Ursane-type SENP1 Inhibitors and the Platinum Resistance Reversal Activity Against Human Ovarian Cancer Cells: A Structure-Activity Relationship Study.
    Journal of natural products, 2022, 05-27, Volume: 85, Issue:5

    Topics: Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cisplatin; Cysteine Endopeptidases; Drug Resistance, Neoplasm; Female; Humans; Molecular Docking Simulation; Ovarian Neoplasms; Structure-Activity Relationship; Triterpenes

2022

Other Studies

2 other study(ies) available for uvaol and 11-keto-boswellic acid

ArticleYear
11beta-Hydroxysteroid dehydrogenase 1 inhibiting constituents from Eriobotrya japonica revealed by bioactivity-guided isolation and computational approaches.
    Bioorganic & medicinal chemistry, 2010, Feb-15, Volume: 18, Issue:4

    Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Biological Assay; Cell Line; Database Management Systems; Drug Evaluation, Preclinical; Enzyme Inhibitors; Eriobotrya; Humans; Magnetic Resonance Spectroscopy; Models, Molecular; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship

2010
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
    Journal of natural products, 2019, 12-27, Volume: 82, Issue:12

    Topics: Cyclooxygenase Inhibitors; Drug Evaluation, Preclinical; Humans; Lipoxygenase Inhibitors; Pentacyclic Triterpenes; Structure-Activity Relationship

2019